UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Extremely High Mutation Rate of HIV-1 In Vivo

PLoS biology, 2015-09, Vol.13 (9), p.e1002251-e1002251

2015

Volltextzugriff (PDF)

Increasing Incidence of Hepatocellular Carcinoma in HIV-Infected Patients in Spain

Clinical infectious diseases, 2013-01, Vol.56 (1), p.143-150

2013

Volltextzugriff (PDF)

Lopinavir-ritonavir monotherapy versus lopinavir-ritonavir and 2 nucleosides for maintenance therapy of HIV: 96-week analysis

Journal of acquired immune deficiency syndromes (1999), 2009-06, Vol.51 (2), p.147-152

2009

Volltextzugriff (PDF)

HIV/hepatitis C virus-coinfected patients who achieved sustained virological response are still at risk of developing hepatocellular carcinoma

AIDS (London), 2014-01, Vol.28 (1), p.41-47

2014

Volltextzugriff (PDF)

Sustained Virological Response to Interferon Plus Ribavirin Reduces Non—Liver-Related Mortality in Patients Coinfected With HIV and Hepatitis C Virus

Clinical infectious diseases, 2012-09, Vol.55 (5), p.728-736

2012

Volltextzugriff (PDF)

Osteonecrosis in patients infected with HIV: clinical epidemiology and natural history in a large case series from Spain

Journal of acquired immune deficiency syndromes (1999), 2006-07, Vol.42 (3), p.286-292

2006

Volltextzugriff (PDF)

Executive summary of the GeSIDA/National AIDS Plan consensus document on antiretroviral therapy in adults infected by the human immunodeficiency virus (updated January 2014)

Enfermedades infecciosas y microbiologia clinica, 2014-08, Vol.32 (7), p.447-458

2014

Volltextzugriff (PDF)

Comparison of the Prognostic Value of Liver Biopsy and FIB-4 Index in Patients Coinfected With HIV and Hepatitis C Virus

Clinical infectious diseases, 2015-03, Vol.60 (6), p.950-958

2015

Volltextzugriff (PDF)

Evolution of HIV-1 genotype in plasma RNA and peripheral blood mononuclear cells proviral DNA after interruption and resumption of antiretroviral therapy

Antiviral therapy, 2012-01, Vol.17 (3), p.577-583

2012

Volltextzugriff (PDF)

The effects of Maraviroc on liver fibrosis in HIV/HCV co‐infected patients

Journal of the International AIDS Society, 2014-11, Vol.17 (4 Suppl 3), p.19643-n/a

2014

Volltextzugriff (PDF)

Fat redistribution syndromes associated with HIV-1 infection and combination antiretroviral therapy

AIDS reviews, 2012-04, Vol.14 (2), p.112-123

2012

Volltextzugriff (PDF)

Executive summary of the GeSIDA/National AIDS Plan consensus document on antiretroviral therapy in adults infected by the human immunodeficiency virus (updated January 2018)

Enfermedades infecciosas y microbiologia clinica (English ed.), 2019-03, Vol.37 (3), p.195-202

2019

Volltextzugriff (PDF)

Analysis of the costs and cost-effectiveness of the guidelines recommended by the 2018 GESIDA/Spanish National AIDS Plan for initial antiretroviral therapy in HIV-infected adults

Enfermedades infecciosas y microbiologia clinica (English ed.), 2019-03, Vol.37 (3), p.151-159

2019

Volltextzugriff (PDF)

Clinical effects of viral relapse after interferon plus ribavirin in patients co-infected with human immunodeficiency virus and hepatitis C virus

Journal of hepatology, 2013-06, Vol.58 (6), p.1104-1112

2013

Volltextzugriff (PDF)

Costs and cost-efficacy analysis of the 2017 GESIDA/Spanish National AIDS Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults

Enfermedades infecciosas y microbiologia clinica, 2018-05, Vol.36 (5), p.268-276

2018

Volltextzugriff (PDF)

Costs and cost-efficacy analysis of the 2016 GESIDA/Spanish AIDS National Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults

Enfermedades infecciosas y microbiologia clinica, 2017-02, Vol.35 (2), p.88-99

2017

Volltextzugriff (PDF)

Short―term and long―term clinical and immunological consequences of stopping antiretroviral therapy in HIV―infected patients with preserved immune function

Antiviral therapy, 2013, Vol.18 (1), p.125-130

2013

Volltextzugriff (PDF)

Effect of accompanying antiretroviral drugs on virological response to pegylated interferon and ribavirin in patients co-infected with HIV and hepatitis C virus

Journal of antimicrobial chemotherapy, 2011-12, Vol.66 (12), p.2843-2849

2011

Volltextzugriff (PDF)

Spanish cohort of naïve HIV-infected patients (CoRIS): rationale, organization and initial results

Enfermedades infecciosas y microbiología clínica, 2007-01, Vol.25 (1), p.23

2007

Volltextzugriff (PDF)

Executive summary: Prevention and treatment of opportunistic infections and other coinfections in HIV-infected patients: May 2015

Enfermedades infecciosas y microbiologia clinica, 2016-10, Vol.34 (8), p.517-523

2016

Volltextzugriff (PDF)

Cardiovascular risk in human immunodeficiency virus-infected patients in Spain. CoRIS cohort, 2011

Enfermedades infecciosas y microbiologia clinica, 2012-11, Vol.30 (9), p.517

2012

Volltextzugriff (PDF)

The future of antiretroviral therapy: challenges and needs

Journal of antimicrobial chemotherapy, 2010-05, Vol.65 (5), p.827-835

2010

Volltextzugriff (PDF)

Executive summary: Pre-exposure prophylaxis for prevention of HIV infection in adults in Spain: July 2016

Enfermedades infecciosas y microbiologia clinica (English ed.), 2017-06, Vol.35 (6), p.377-383

2017

Volltextzugriff (PDF)

Co-ocurrence of myasthenia gravis with Parkinson's disease: A not to be missed diagnosis

Geriatrics & gerontology international, 2016-04, Vol.16 (4), p.528-530

2016

Volltextzugriff (PDF)

Clinical Utility of Maraviroc

Clinical drug investigation, 2011-01, Vol.31 (8), p.527-542

2011

Volltextzugriff (PDF)

1 – 25 von 139

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(134)
Mit Volltextzugriff
(111)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Extremely High Mutation Rate of HIV-1 In Vivo

Increasing Incidence of Hepatocellular Carcinoma in HIV-Infected Patients in Spain

Lopinavir-ritonavir monotherapy versus lopinavir-ritonavir and 2 nucleosides for maintenance therapy of HIV: 96-week analysis

HIV/hepatitis C virus-coinfected patients who achieved sustained virological response are still at risk of developing hepatocellular carcinoma

Sustained Virological Response to Interferon Plus Ribavirin Reduces Non—Liver-Related Mortality in Patients Coinfected With HIV and Hepatitis C Virus

Osteonecrosis in patients infected with HIV: clinical epidemiology and natural history in a large case series from Spain

Executive summary of the GeSIDA/National AIDS Plan consensus document on antiretroviral therapy in adults infected by the human immunodeficiency virus (updated January 2014)

Comparison of the Prognostic Value of Liver Biopsy and FIB-4 Index in Patients Coinfected With HIV and Hepatitis C Virus

Evolution of HIV-1 genotype in plasma RNA and peripheral blood mononuclear cells proviral DNA after interruption and resumption of antiretroviral therapy

The effects of Maraviroc on liver fibrosis in HIV/HCV co‐infected patients

Fat redistribution syndromes associated with HIV-1 infection and combination antiretroviral therapy

Executive summary of the GeSIDA/National AIDS Plan consensus document on antiretroviral therapy in adults infected by the human immunodeficiency virus (updated January 2018)

Analysis of the costs and cost-effectiveness of the guidelines recommended by the 2018 GESIDA/Spanish National AIDS Plan for initial antiretroviral therapy in HIV-infected adults

Clinical effects of viral relapse after interferon plus ribavirin in patients co-infected with human immunodeficiency virus and hepatitis C virus

Costs and cost-efficacy analysis of the 2017 GESIDA/Spanish National AIDS Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults

Costs and cost-efficacy analysis of the 2016 GESIDA/Spanish AIDS National Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults

Short―term and long―term clinical and immunological consequences of stopping antiretroviral therapy in HIV―infected patients with preserved immune function

Effect of accompanying antiretroviral drugs on virological response to pegylated interferon and ribavirin in patients co-infected with HIV and hepatitis C virus

Spanish cohort of naïve HIV-infected patients (CoRIS): rationale, organization and initial results

Executive summary: Prevention and treatment of opportunistic infections and other coinfections in HIV-infected patients: May 2015

Cardiovascular risk in human immunodeficiency virus-infected patients in Spain. CoRIS cohort, 2011

The future of antiretroviral therapy: challenges and needs

Executive summary: Pre-exposure prophylaxis for prevention of HIV infection in adults in Spain: July 2016

Co-ocurrence of myasthenia gravis with Parkinson's disease: A not to be missed diagnosis

Clinical Utility of Maraviroc

Suchergebnisse filtern